Jonathon B. Cohen
乔纳森·科恩
MD, MS
Associate Professor of Hematology and Medical Oncology; Lymphoma Program Director血液肿瘤科副教授；淋巴瘤项目主任
👥Biography 个人简介
Jonathon B. Cohen, MD, MS is Director of the Lymphoma Program at Emory Winship Cancer Institute. He is a leading investigator for axicabtagene ciloleucel in DLBCL and was among principal investigators for epcoritamab (CD3xCD20 bispecific) trials, contributing to its FDA approval for relapsed/refractory large B cell lymphoma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
CAR-T and Bispecific Antibody Trials in DLBCL
Served as site PI for ZUMA and EPCORE NHL trials, advancing axicabtagene ciloleucel and epcoritamab through pivotal studies that led to FDA approvals for relapsed/refractory DLBCL.
Real-World CAR-T Outcomes Research
Conducted real-world analyses of CAR-T cell therapy outcomes in DLBCL patients treated outside clinical trials, characterizing toxicity management and efficacy in broader populations.
Representative Works 代表性著作
Epcoritamab, a Novel Bispecific CD3×CD20 Antibody in an All-Comer Population of Patients with Relapsed/Refractory B-Cell NHL
Journal of Clinical Oncology (2023)
Pivotal EPCORE NHL-1 dose-expansion results supporting epcoritamab approval in relapsed/refractory large B cell lymphoma.
Real-world outcomes of axicabtagene ciloleucel for large B-cell lymphoma outside of clinical trial
Blood Advances (2021)
Real-world analysis demonstrating comparable efficacy of axi-cel in standard practice vs clinical trial settings for relapsed/refractory DLBCL.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 乔纳森·科恩 的研究动态
Follow Jonathon B. Cohen's research updates
留下邮箱，当我们发布与 Jonathon B. Cohen（Emory University Winship Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment